Board of Directors
Awards & Partnerships
Exiqon operates in two business areas where our proprietary
Locked Nucleic Acid (LNA™) detection technology provides a competitive advantage.
The home of the popular LNA™-based tools for small RNA research. We also provide useful experimental advice, recommended literature and lots of valuable downloads.
miRCURY LNA™ products for microRNA Research
MicroRNA Array & PCR Services
Scientific publications and downloads
Visit Life Sciences
Exiqon Diagnostics is a market leader in the field of
treatment selection testing for cancer, and performs innovative genomic research aimed at rapidly identifying new cancer diagnostics to improve the outcome for cancer patients.
cancer therapy selection testing
Molecular cancer diagnostics
Cancer prognostic testing
Cookies on Exiqon's website.